# CSL Limited

Source: https://onco.cc/companies/csl/  
OnCo record `csl` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CSL is the Australian plasma-products and vaccines group whose CSL Behring arm makes immunoglobulins and clotting factors used in supportive cancer care, and which has sponsored phase 3 trials in cancer settings.

## Summary

CSL Limited, listed in Melbourne since 1994 and descended from the Commonwealth Serum Laboratories, is one of the world's largest plasma-derived medicines makers through CSL Behring, based in King of Prussia, Pennsylvania, alongside its Seqirus vaccines business. In oncology its products are supportive: immunoglobulin replacement for patients with blood cancers or after CAR-T therapy, and haemostatic agents. ClinicalTrials.gov lists CSL Behring as lead sponsor of phase 3 trials in cancer-related settings.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: CSL Behring; CSL Behring LLC; CSL Behring GmbH; Commonwealth Serum Laboratories
- Tags: ctgov-sponsor
- HQ: Melbourne
- Type: pharma
- Website: https://www.csl.com

## Sources

- Official website: https://www.csl.com
- ClinicalTrials.gov: trials led by CSL Behring: https://clinicaltrials.gov/search?lead=CSL%20Behring
- Wikidata: https://www.wikidata.org/wiki/Q908265

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/csl.json